Loading…
Novanta Inc. is projected to rise to $207.70 by 2027, a +37% move from its current price of $151.66. NOVT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $147.76 | $151.75 | $155.86 | +0.06% |
| Jul 14 | $146.23 | $151.85 | $157.68 | +0.12% |
| Jul 15 | $145.08 | $151.94 | $159.12 | +0.18% |
| Jul 16 | $144.14 | $152.03 | $160.36 | +0.25% |
| Jul 17 | $143.32 | $152.13 | $161.48 | +0.31% |
| Jul 18 | $142.59 | $152.22 | $162.50 | +0.37% |
| Jul 19 | $141.94 | $152.31 | $163.45 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $141.94 | $152.31 | $163.45 | +0.43% |
| Week 2 | $138.44 | $152.97 | $169.03 | +0.87% |
| Week 3 | $135.96 | $153.63 | $173.61 | +1.30% |
| Week 4 | $133.99 | $154.30 | $177.68 | +1.74% |
| Week 5 | $132.34 | $154.96 | $181.45 | +2.18% |
| Week 6 | $130.93 | $155.63 | $185.00 | +2.62% |
| Week 7 | $129.68 | $156.30 | $188.39 | +3.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Novanta Inc. and its subsidiaries operate in technology sectors spanning precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.
The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications.
The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc.
in May 2016. Novanta was incorporated in 1968 and is based in Bedford, Massachusetts.
Novanta Inc. trades at $155.30 per share and has a market capitalization of $5.53B, ranking 1286 by market cap.
The stock’s near-term technical backdrop shows a bullish tilt with a current price above notable moving averages and a neutral-to-bullish RSI posture. The 50-day simple moving average stands at $145.59, while the 200-day simple moving average sits at $126.94, placing the price comfortably above both.
Fundamental and forecast data imply a strong upside trajectory over the longer term. The 2026 forecast shows an average price of $155.30, with a high projected price of $230.13 and a low of $111.14, and an overall neutral sentiment in that initial year. Beyond 2026, the model depicts sustained upside with progressively higher average prices through 2050, including a 2030 average of $263.22 and a 2050 average of $1,327.23 alongside a maximum of $2,373.02.
A major floor 25.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.5% away) — a key level to hold.
The nearest ceiling, 11.2% above — a clean break opens room to run.
A major ceiling 17.7% above — clearing it would confirm fresh momentum.
Key NOVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NOVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $153.93 | Sell | $154.57 | Sell |
| MA 10 | $157.26 | Sell | $155.69 | Sell |
| MA 20 | $156.67 | Sell | $156.27 | Sell |
| MA 50 | $153.15 | Sell | $151.87 | Sell |
| MA 100 | $140.36 | Buy | $144.22 | Buy |
| MA 200 | $129.86 | Buy | $137.21 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.87 | Neutral |
| Stoch RSI (14) | 51.83 | Neutral |
| CCI (20) | -0.37 | Neutral |
| Williams %R (14) | -48.36 | Info |
| MACD (12,26,9) | -1.01 | Sell |
| ROC (12) | 3.51 | Buy |
| Bollinger %B (20,2) | 0.50 | Neutral |
| Stochastic %K (14) | 51.64 | Neutral |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | -4.64 | Sell |
| Ultimate (7,14,28) | 45.27 | Neutral |
| Momentum (10) | -3.78 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 148.77 | Buy |
| ADX (14) | 12.91 | Neutral |
| ATR (14) | 4.05 | Info |
Near-term sentiment is bullish, with the stock price generally supported by strong technicals. The RSI is 50, and the price trades above the 50-day SMA of $145.59 and the 200-day SMA of $126.94, underscoring a constructive trajectory. The 30-day range runs from a low of $131.81 to a high of $182.98, with a defined support at $136.28 and resistance at $168.59.
The combination of bullish sentiment and the position above key moving averages suggests potential for further near-term gains, with traders watching the $168.59 resistance as a possible near-term target while the $136.28 level remains a nearby base of support.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $111.14 | $151.66 | $220.90 | 0% | Neutral | |
| $165.70 | $207.70 | $275.22 | +37% | Bullish | |
| $178.51 | $229.92 | $315.89 | +52% | Bullish | |
| $182.57 | $240.50 | $339.93 | +59% | Bullish | |
| $198.71 | $267.02 | $386.53 | +76% | Bullish | |
| $217.06 | $297.00 | $438.98 | +96% | Bullish | |
| $242.23 | $337.07 | $507.60 | +122% | Bullish | |
| $295.55 | $417.79 | $639.92 | +175% | Bullish | |
| $312.59 | $448.57 | $697.85 | +196% | Bullish | |
| $302.71 | $440.66 | $695.54 | +191% | Bullish | |
| $450.02 | $699.08 | $1,172.49 | +361% | Bullish | |
| $807.61 | $1,402.62 | $2,570.26 | +825% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $111.14 | $151.66 | $180.97 | +0.00% |
| August 2026 | $129.12 | $152.33 | $184.50 | +0.44% |
| September 2026 | $135.05 | $160.42 | $196.40 | +5.31% |
| October 2026 | $141.74 | $169.35 | $209.23 | +5.57% |
| November 2026 | $143.07 | $171.78 | $213.87 | +1.44% |
| December 2026 | $146.06 | $176.19 | $220.90 | +2.57% |
Click any year to see its month-by-month NOVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NOVT price prediction for 2026 points to an average of $151.66 (low $111.14, high $220.90) — a potential gain of 0% on today's $151.66. Price action looks broadly range-bound.
In 2027, NOVT is projected to trade between $165.70 and $275.22, averaging $207.70 — a potential gain of +37% from today's $151.66. That is up +37% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Novanta Inc.'s 2028 outlook centres on $229.92, within a $178.51 to $315.89 range. That is up +11% on the projected 2027 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2029, NOVT could reach as high as $339.93, with a base case around $240.50 and support toward $182.57 — roughly +59% from $151.66. Buyers look set to stay in control over this stretch.
Expect NOVT to range from $198.71 to $386.53 through 2030. The $267.02 average target implies a +76% move from current prices. That is up +11% on the projected 2029 average. Momentum favours further upside here.
The NOVT price prediction for 2031 points to an average of $297.00 (low $217.06, high $438.98) — a potential gain of +96% on today's $151.66. Buyers look set to stay in control over this stretch.
In 2032, NOVT is projected to trade between $242.23 and $507.60, averaging $337.07 — a potential gain of +122% from today's $151.66. That is up +13% on the projected 2031 average. Momentum favours further upside here.
Novanta Inc.'s 2033 outlook centres on $417.79, within a $295.55 to $639.92 range. That is up +24% on the projected 2032 average. That marks a +175% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NOVT could reach as high as $697.85, with a base case around $448.57 and support toward $312.59 — roughly +196% from $151.66. Momentum favours further upside here.
Expect NOVT to range from $302.71 to $695.54 through 2035. The $440.66 average target implies a +191% move from current prices. That is -2% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The NOVT price prediction for 2040 points to an average of $699.08 (low $450.02, high $1,172.49) — a potential gain of +361% on today's $151.66. Momentum favours further upside here.
In 2050, NOVT is projected to trade between $807.61 and $2,570.26, averaging $1,402.62 — a potential gain of +825% from today's $151.66. That is up +101% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NOVT today (≈ 6.593696 NOVT) could be worth
$9,248.43
+$8,248.43 (+825%) by 2050 · US Dollar
Based on the average projected NOVT price of $1,402.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NOVTwould be worth at today's price.
$1,000 invested in NOVT on Jul 10, 2025 (≈ 7.475517 NOVT) would be worth
$1,133.74
+$133.74 (+13.4%) today · 1.13× · US Dollar
Based on a NOVT entry price of $133.77 vs. today's $151.66.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $161.72 | $937.79 | -6.2% |
| 1 month ago | $154.58 | $981.11 | -1.9% |
| 3 months ago | $125.23 | $1,211.05 | +21.1% |
| 6 months ago | $128.96 | $1,176.02 | +17.6% |
| 1 year ago | $133.77 | $1,133.74 | +13.4% |
| All time (5.0y) ago | $135.96 | $1,115.48 | +11.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NOVT forecast.
Our base-case forecast reaches $300.00 around 2032.
Implied market cap at $300.00: $10.68B
The multi-year forecast envisions a sustained rise in value with broad-based upside across the horizon. The 2026 average is $155.30 (the current price) with a max of $230.13 and a min of $111.14, yielding an ROI of 0% for that year. In 2027, the average climbs to $208.48 (ROI 34.3%), and the 2028 average is $227.22 (ROI 46.3%), followed by 2029 at $246.58 (ROI 58.8%).
By 2030 the average is $263.22 (ROI 69.5%), and 2031 shows $287.33 (ROI 85%). The trajectory continues higher with 2032 at $336.05 (ROI 116.4%), 2033 at $402.25 (ROI 159%), 2034 at $427.35 (ROI 175.2%), and 2035 at $428.48 (ROI 175.9%). The forecast rises sharply thereafter to $654.68 in 2040 (ROI 321.6%) and $1,327.23 in 2050 (ROI 754.6%), with a bullish overall sentiment for the long horizon.
These are projection figures and not guarantees. They illustrate potential upside under the stated assumptions and should be interpreted as estimates rather than financial advice.
Tap a question to reveal the answer.
2030 avg $263.22; min $197.93; max $376.35; ROI 69.5%; sentiment BULLISH.
Forecasts show a bullish sentiment from 2027 onward with rising averages toward 2050, while 2026 is neutral. Key long-horizon targets include $263.22 average in 2030 and $1,327.23 average in 2050, with substantial upside indicated by the max of $2,373.02 in 2050.
The forecasted average price for 2050 is $1,327.23, indicating potential to exceed $1,000 by 2050. The 2040 average is $654.68, so the $1,000 level is not projected for 2040 in the given data.
Current price is $155.30. The 30-day range is $131.81 to $182.98.
Long-term figures show the average price rising from $155.30 in 2026 to $263.22 in 2030, $654.68 in 2040, and $1,327.23 in 2050, with max values reaching $376.35 (2030) and $2,373.02 (2050) and ROIs up to 754.6% by 2050.
Novanta Inc. Community Discussion
0Share your Novanta Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.